Nephros Q3 EPS $(0.02) Beats $(0.06) Estimate, Sales $3.74M Beat $3.35M Estimate
Portfolio Pulse from bharat@benzinga.com
Nephros (NASDAQ:NEPH) reported Q3 losses of $(0.02) per share, beating the analyst consensus estimate of $(0.06) by 66.67%. This is an 83.33% increase over losses from the same period last year. The company also reported quarterly sales of $3.74 million, beating the analyst consensus estimate of $3.35 million by 11.70%. This is a 55.33% increase over sales from the same period last year.
November 08, 2023 | 9:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nephros reported better than expected Q3 results with both EPS and sales beating estimates. The company's losses per share improved significantly YoY, and sales also saw a substantial increase.
Nephros reported better than expected Q3 results, with both EPS and sales beating estimates. This indicates a strong financial performance, which is likely to positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100